.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Citi
US Department of Justice
Queensland Health
Colorcon
Healthtrust
Julphar
Daiichi Sankyo
Novartis

Generated: July 26, 2017

DrugPatentWatch Database Preview

Phenelzine sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for phenelzine sulfate and what is the scope of phenelzine sulfate freedom to operate?

Phenelzine sulfate
is the generic ingredient in two branded drugs marketed by Parke Davis and Novel Labs Inc, and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for phenelzine sulfate. Five suppliers are listed for this compound.

Summary for Generic Name: phenelzine sulfate

Tradenames:2
Patents:1
Applicants:2
NDAs:2
Drug Master File Entries: see list4
Suppliers / Packagers: see list5
Bulk Api Vendors: see list22
Clinical Trials: see list642
Patent Applications: see list1,325
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:phenelzine sulfate at DailyMed

Pharmacology for Ingredient: phenelzine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs Inc
PHENELZINE SULFATE
phenelzine sulfate
TABLET;ORAL200181-001Dec 8, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
NARDIL
phenelzine sulfate
TABLET;ORAL011909-002Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Johnson and Johnson
Citi
Baxter
Healthtrust
Merck
Harvard Business School
Moodys
QuintilesIMS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot